RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication
Artículo científico (JournalArticle)
Identification of Candidates for MASLD Treatment With Indeterminate Vibration-Controlled Transient Elastography
[EN] BACKGROUND AND AIMS: A noteworthy proportion of patients with metabolic dysfunction-associated steatotic liver disease (MASLD) have an indeterminate vibration-controlled transient elastography (VCTE). Among these patients, we aimed to identify candidates for MASLD treatment by diagnosing significant fibrosis. METHODS: This was a real-world prospective study including a large dataset of MASLD patients with paired VCTE and liver biopsy from 6 centers. A total of 1196 patients were recruited and divided in training (3 centers, Spain), internal validation (2 centers, Spain), and external validation (1 center, United States) cohorts. In patients with indeterminate liver stiffness measurement (LSM) (8-12 kPa), a diagnostic algorithm was developed to identify significant fibrosis, defined as histological stage >= F2. Statistical analysis was performed using Gaussian mixture model (GMM) and k-means unsupervised clusterization. RESULTS: From the eligible population, 33%, 29%, and 31% had indeterminate VCTE in the training, internal and external validation samples, respectively. The controlled attenuation parameter allowed the differentiation of GMM clusters with a cutoff of 280 dB/m (area under the curve, 0.89; 95% confidence interval, 0.86-0.97). Within patients with <280 dB/m, a LSM between 8.0-9.0 kPa showed a 93% sensitivity and a 91% negative predictive value to exclude significant fibrosis. Among patients with >= 280 dB/m, a LSM between 10.3 and 12.0 kPa diagnosed significant fibrosis with a 91% specificity. Applying this algorithm to the validation cohorts, 36% of the indeterminate VCTE were reallocated. The reallocated high-risk group showed a prevalence of 86% significant fibrosis, opening the therapeutic window for MASLD patients. CONCLUSIONS: To identify candidates for MASLD treatment among indeterminate VCTE, an algorithm-based on the sequential combination of LSM and controlled attenuation parameter thresholds can optimize the diagnosis of moderate-to-advanced fibrosis., This study was funded by the Spanish Association for the Study of the Liver (Juan Cordoba Award, 2024/064) and the Sociedad Valenciana de Patologia Digestiva (2021/094) . The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Rohit Loomba receives funding support from the National Center for Advancing Translational Sciences (5UL1TR001442) , the National Institute of Diabetes and Digestive and Kidney Diseases (U01DK061734, U01DK130190, R01DK106419, R01DK121378, R01DK124318, P30DK120515) , the National Heart, Lung, and Blood Institute (P01HL147835) , the John C. Martin Foundation (RP124) , and the National Institute on Alcohol Abuse and Alcoholism (U01AA029019) . David Marti-Aguado is a recipient of a Joan Rodes award (JR22/00002) from the Instituto de Salud Carlos III (Spanish Ministry of Science and Innovation) and received a grant Grupo de Investigacion Emergente (CIGE/2023/37) from Conselleria de Innovacion, Universidades, Ciencia y Sociedad Digital, Generalitat Valenciana, Spain.
Project:
Generalitat Valenciana CIGE/2023/37
,
National Institute on Drug Abuse U01AA029019
,
EEUU P01HL147835
,
National Heart JR22/00002
,
Lung 5UL1TR001442
,
and Blood Institute U01DK061734
,
EEUU R01DK121378
,
Ministerio de Ciencia e Innovación R01DK124318
,
NCATS P30DK120515
,
NIDDK U01DK130190
,
NIDDK R01DK106419